Research Training Groups in the Mathematical Sciences (RTG)
Full Proposal Deadline Date: June 7, 2022 Program Guidelines: NSF 20-608The long-range goal of the Research Training Groups in the Mathematical Sciences (RTG) program is to strengthen the nation's scientific competitiveness by increasing the number of well-prepared U.S. citizens, nationals, and permanent residents who pursue careers in the mathematical sciences, be they in academia, government, or industry. The RTG program supports efforts to improve research training by involving undergraduate students, graduate students, postdoctoral associates, and faculty ...More at https://beta.nsf.gov/programid/5732This is an NSF Upc...
Source: NSF Upcoming Due Dates - May 8, 2022 Category: Science Source Type: funding
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional)
Funding Opportunity PAR-22-144 from the NIH Guide for Grants and Contracts. Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA supports a research program...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 6, 2022 Category: Research Source Type: funding
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U01 Clinical Trial Optional)
Funding Opportunity PAR-22-143 from the NIH Guide for Grants and Contracts. Reissue of PAR-20-118. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA using the U01 mechanism sup...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 6, 2022 Category: Research Source Type: funding
Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-146 from the NIH Guide for Grants and Contracts. This FOA solicits Research Education Grant (R25) applications to develop and implement a short course focused on (1) steps required for successful medical device development, translation, and commercialization (2) common technical and strategic challenges, and (3) best-practices and resources for each stage in the process. Applicants may choose to include an extended mentorship plan if they see fit. The short course should address a broad audience, including senior post-doctoral fellows, independent academic researchers, clinician scientists, an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 28, 2022 Category: Research Source Type: funding
Partnerships for International Research and Education (PIRE)
Full Proposal Deadline Date: May 25, 2022 Program Guidelines: NSF 22-546
This PIRE competition invites visionary, ambitious, interdisciplinary, use-inspired research proposals that address scientific challenges related to climate change and/or clean energy.
Many cutting-edge research questions require international collaboration to achieve important advances. They also require insights from diverse disciplines to address the full complexity of the research, as well as active participation of stakeholders outside of academia to ...More at https://beta.nsf.gov/programid/505038This is an NSF Upcoming Due Dates item. (Sourc...
Source: NSF Upcoming Due Dates - April 25, 2022 Category: Science Source Type: funding
Notice of NIDA's Participation in PAR-21-277, " Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
Notice NOT-DA-22-057 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 12, 2022 Category: Research Source Type: funding
Notice of NICHD Participation in PAR-21-273, Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Require
Notice NOT-HD-22-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 30, 2022 Category: Research Source Type: funding
Notice of NICHD Participation in PAR-21-272, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required)"
Notice NOT-HD-22-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 30, 2022 Category: Research Source Type: funding
ADVANCE: Organizational Change for Gender Equity in STEM Academic Professions (ADVANCE)
Preliminary Proposal Target Date: April 28, 2022 IT-Preliminary proposal Target Date - preliminary proposals are only required for institutions of higher education that want to submit a full Institutional Transformation proposal. IT-preliminary proposals are accepted before and after the target date. Program Guidelines: NSF 20-554The NSF ADVANCE program contributes to the National Science Foundation's goal of a more diverse and capable science and engineering workforce.1 In this solicitation, the NSF ADVANCE program seeks to build on prior NSF ADVANCE work and other research and literature concerning gender, racial, and et...
Source: NSF Upcoming Due Dates - March 29, 2022 Category: Science Source Type: funding
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2022 Category: Research Source Type: funding
Expanding Capacity in Quantum Information Science and Engineering (ExpandQISE)
Letter of Intent Deadline Date: April 1, 2022 Track 2 proposals Program Guidelines: NSF 22-561The NSF Expanding Capacity in Quantum Information Science and Engineering (ExpandQISE) program aims to increase research capacity and broaden participation in Quantum Information Science and Engineering (QISE) and related disciplines through the creation of a diversified investment portfolio in research and education that will lead to scientific and engineering breakthroughs, while securing a talent pipeline in a field where workforce needs of industry, government and academia continue to ...More at https://beta.nsf.gov/programid/...
Source: NSF Upcoming Due Dates - March 16, 2022 Category: Science Source Type: funding
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-022 from the NIH Guide for Grants and Contracts. This funding opportunity will support high risk, milestone-driven research for the development of innovative assays designed to enable the measurement of HIV susceptibility to broadly neutralizing antibodies (bNAbs) in clinical laboratories. Proposed studies should target early-stage assay development and demonstrate feasibility and clinical utility, followed by verification and late stage validation of the method. Collaborative, interdisciplinary research with partnerships between academia and industry is strongly encouraged. (Source: NIH Fu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 10, 2022 Category: Research Source Type: funding
Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
Funding Opportunity PAR-22-107 from the NIH Guide for Grants and Contracts. The Centers of Excellence in Genomic Science (CEGS) program establishes academic Centers for advanced genome research. Each CEGS award supports a multi-investigator, interdisciplinary team to develop transformative genomic approaches to address a biomedical problem. A CEGS project will address a critical issue in genomic science, genomic medicine, or computational genomics, proposing a highly innovative solution that would be a major advance. The research will entail substantial risk, balanced by outstanding scientific and management plans and v...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 8, 2022 Category: Research Source Type: funding
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 8, 2022 Category: Research Source Type: funding
FY 2021 By the Numbers: Extramural Grant Investments in Research
Building on my 2021 reflections from January, we are presenting fiscal year (FY) 2021 extramural investments in research. The grant funding and success rate data presented here are in line with other related “By The Numbers” posts focusing on NIH’s annual enacted appropriations. Historical data may be found in the NIH Data Book, with FY 2021 data to be published soon. Spending related to special appropriations for coronavirus may be found using RePORTER’s advanced search capabilities.
In FY2021 NIH spent $32.3 billion of its total $42.9 billion appropriation for competing and noncompeting awards . This is a 5.1...
Source: NIH Extramural Nexus - March 7, 2022 Category: Research Authors: Mike Lauer Tags: blog Open Mike awards grants Success Rate Source Type: funding
